ACCESS THE CONTENT HUB
Tokenization of patient data is well established in the commercial setting, but it is also applicable within clinical trials. It enables sponsors to link participant information in a blinded and encrypted way beyond the study setting, for better intelligence on health care outcomes and the development of more effective, safer drugs. Nonetheless, as with much evolution in the pharma industry, a lack of understanding around the concept could be a barrier to utilizing its full potential.
Scrip, in collaboration with ICON, is pleased to bring you a variety of content aimed at explaining this exciting new focus area within clinical trials. Register below to explore the potential benefits clinical trial tokenization has to offer both the industry and the patient.